Skip to main content
. Author manuscript; available in PMC: 2021 May 11.
Published in final edited form as: Nature. 2020 Nov 11;588(7839):693–698. doi: 10.1038/s41586-020-2911-7

Extended Data Fig. 10. A schematic diagram illustrating PCSK9-mediated degradation of MHC I in the lysosome.

Extended Data Fig. 10.

In the presence of PCSK9, MHC I is transported into the lysosome and degraded (left panel). In the absence of PCSK9, either because of genetic deletion or antibody neutralization, MHC I levels on the surface remains high and is thus able to present tumor-specific peptic antigens more efficiently to T cells (right panel). Illustration by Stan Coffman.